Cargando…

Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and Immunotherapy

In recent years, protein arginine methyltransferases (PRMTs) have emerged as new members of a gene expression regulator family in eukaryotes, and are associated with cancer pathogenesis and progression. Cancer immunotherapy has significantly improved cancer treatment in terms of overall survival and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Weijing, Zhang, Jianguo, Li, Siqi, He, Fajian, Liu, Qiao, Gong, Jun, Yang, Zetian, Gong, Yan, Tang, Fang, Wang, Zhihao, Xie, Conghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046588/ https://www.ncbi.nlm.nih.gov/pubmed/35493527 http://dx.doi.org/10.3389/fimmu.2022.865964

Ejemplares similares

GPR87 promotes tumor cell invasion and mediates the immunogenomic landscape of lung adenocarcinoma
por: Bai, Rui, et al.
Publicado: (2022)

SETD2 mediates immunotherapy and radiotherapy efficacy via regulating DNA damage responses and genomic stability in lung adenocarcinoma
por: Zeng, Zihang, et al.
Publicado: (2022)

Prospects and feasibility of synergistic therapy with radiotherapy, immunotherapy, and DNA methyltransferase inhibitors in non-small cell lung cancer
por: Jie, Chen, et al.
Publicado: (2023)

Histone acetylation-related IncRNA: Potential biomarkers for predicting prognosis and immune response in lung adenocarcinoma, and distinguishing hot and cold tumours
por: Li, Rumeng, et al.
Publicado: (2023)

Editorial: Post-translational modifications of proteins in cancer immunity and immunotherapy
por: Dai, Xiangpeng, et al.
Publicado: (2022)

ATG7 promotes the tumorigenesis of lung cancer but might be dispensable for prognosis predication: a clinicopathologic study
por: Sun, Shaoxing, et al.
Publicado: (2016)

Emerging role of deubiquitination modifications of programmed death-ligand 1 in cancer immunotherapy
por: Jiang, Yao, et al.
Publicado: (2023)

Editorial: Community series in post-translational modifications of proteins in cancer immunity and immunotherapy, volume II
por: Nihira, Naoe Taira, et al.
Publicado: (2023)

Developing an m5C regulator–mediated RNA methylation modification signature to predict prognosis and immunotherapy efficacy in rectal cancer
por: Zhang, Rixin, et al.
Publicado: (2023)

Circulating sepsis-related metabolite sphinganine could protect against intestinal damage during sepsis
por: Wang, Zetian, et al.
Publicado: (2023)

Lysine Acetylation/Deacetylation Modification of Immune-Related Molecules in Cancer Immunotherapy
por: Ding, Peng, et al.
Publicado: (2022)

Targeting the arginine metabolic brake enhances immunotherapy for leukaemia
por: Mussai, Francis, et al.
Publicado: (2019)

Emerging Perspectives of RNA N(6)-methyladenosine (m(6)A) Modification on Immunity and Autoimmune Diseases
por: Tang, Lipeng, et al.
Publicado: (2021)

Advances in post-translational modifications of proteins and cancer immunotherapy
por: Li, Yanqing, et al.
Publicado: (2023)

Editorial: Emerging talents in cancer immunity and immunotherapy: 2022
por: Maeurer, Markus
Publicado: (2023)

N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy
por: Guo, Liting, et al.
Publicado: (2021)

Immune-infiltrating signature-based classification reveals CD103(+)CD39(+) T cells associate with colorectal cancer prognosis and response to immunotherapy
por: Luo, Yang, et al.
Publicado: (2022)

Revealing the role of regulatory T cells in the tumor microenvironment of lung adenocarcinoma: a novel prognostic and immunotherapeutic signature
por: Zhang, Pengpeng, et al.
Publicado: (2023)

Roles and therapeutic implications of m6A modification in cancer immunotherapy
por: Pan, Juan, et al.
Publicado: (2023)

Emerging Role of Exosomes in Tuberculosis: From Immunity Regulations to Vaccine and Immunotherapy
por: Sun, Yin-Fu, et al.
Publicado: (2021)

Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors
por: Roy, Dia, et al.
Publicado: (2023)

LRPPRC facilitates tumor progression and immune evasion through upregulation of m(6)A modification of PD-L1 mRNA in hepatocellular carcinoma
por: Wang, Houhong, et al.
Publicado: (2023)

Interaction modulation through arrays of clustered methyl-arginine protein modifications
por: Woodsmith, Jonathan, et al.
Publicado: (2018)

Arginine Metabolism in Myeloid Cells Shapes Innate and Adaptive Immunity
por: Rodriguez, Paulo C., et al.
Publicado: (2017)

Regulation of post-translational modification of PD-L1 and advances in tumor immunotherapy
por: Feng, Chong, et al.
Publicado: (2023)

Current Advance of Immune Evasion Mechanisms and Emerging Immunotherapies in Renal Cell Carcinoma
por: Jian, Yuli, et al.
Publicado: (2021)

One Stone, Two Birds: N6-Methyladenosine RNA Modification in Leukemia Stem Cells and the Tumor Immune Microenvironment in Acute Myeloid Leukemia
por: Ouyang, Xianfeng, et al.
Publicado: (2022)

Protein arginine methylation: an emerging regulator of the cell cycle
por: Raposo, Anita E., et al.
Publicado: (2018)

Four Types of RNA Modification Writer-Related lncRNAs Are Effective Predictors of Prognosis and Immunotherapy Response in Serous Ovarian Carcinoma
por: Ye, Lele, et al.
Publicado: (2022)

Emergence of the CD226 Axis in Cancer Immunotherapy
por: Conner, Michael, et al.
Publicado: (2022)

Emerging roles of the gut microbiota in cancer immunotherapy
por: Shi, Zhuangzhuang, et al.
Publicado: (2023)

m6A Regulator-Mediated Tumour Infiltration and Methylation Modification in Cervical Cancer Microenvironment
por: Zhang, Wenyi, et al.
Publicado: (2022)

Comprehensive analysis of m6A RNA methylation modification patterns and the immune microenvironment in osteoarthritis
por: Liu, Zhixin, et al.
Publicado: (2023)

m(6)A Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Pancreatic Cancer
por: Sun, Mengyu, et al.
Publicado: (2021)

Immune landscape and immunotherapy for penile cancer
por: Tang, Yaxiong, et al.
Publicado: (2022)

“Of Mice and Men”: Arginine Metabolism in Macrophages
por: Thomas, Anita C., et al.
Publicado: (2014)

Inflammasomes: Emerging Central Players in Cancer Immunology and Immunotherapy
por: Karan, Dev
Publicado: (2018)

Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas
por: Zeng, Jiayi, et al.
Publicado: (2021)

Immunosuppressive adenosine-targeted biomaterials for emerging cancer immunotherapy
por: Wei, Qi, et al.
Publicado: (2022)

Methylation changes induced by a glycodendropeptide immunotherapy and associated to tolerance in mice
por: Núñez, Rafael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_11egq5alur3cb7qs4na7oihgjl